Intensity Therapeutics, Inc. (INTS) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the Intensity Therapeutics second quarter 2026 financial results conference call. Joining the call today is Lewis H. Bender, Intensity's president and CEO, and Joseph Talamo, Intensity's chief financial officer. Shortly before this call, Intensity issued a press release announcing its second quarter 2026 financial results. which is available under the news and events section of the company's website. Shortly after this webcast, a replay of this call will also be posted. Before we begin, the company reminds you that comments made by management during this conference call contain forward-looking statements that involve risks and uncertainties regarding the operations and future results of Intensity Therapeutics. These statements include but are not limited to Statements relating to the company's expected future plans, cash runway, development activities, projected milestones, business activities or results. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results or events to material differ from those anticipated. Additional information regarding these risks and uncertainties is included in the company's earnings release issued today. For a more complete list and description of risk factors, they encourage you to review the company's filings with the Securities and Exchange Commission, including, without limitation, its forms 10-K, 10-Q, and 8-Ks. Furthermore, the content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, Tuesday, August 11, 2026. Except as required by law, the company disclaims any intention or obligation to update or revise any forward-looking statements. I wi...